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Abstract The majority of cardiac rehabilitation (CR) refer-
rals consist of patients who have survived an acute coronary
syndrome (ACS). Although major changes have been
implemented in ACS treatment since the 1980s, which
highly influenced mortality and morbidity, CR programs
have barely changed and only few data are available on
the optimal CR format in these patients. We postulated that
standard CR programs followed by relatively brief mainte-
nance programs and booster sessions, including behavioural
techniques and focusing on incorporating lifestyle changes
into daily life, can improve long-term adherence to lifestyle
modifications. These strategies might result in improved
(cardiac) mortality and morbidity in a cost-effective fashion.
In the OPTImal CArdiac REhabilitation (OPTICARE) trial
we will assess the effects of two advanced and extended CR
programs that are designed to stimulate permanent adaption
of a heart-healthy lifestyle, compared with current standard
CR, in ACS patients. We will study the effects in terms of
cardiac risk profile, levels of daily physical activity, quality
of life and health care consumption.
Keywords Acute coronary syndrome . Secondaryprevention .
Cardiac rehabilitation . Active lifestyle . Cardiovascular risk
factors . Health behaviour
Introduction
Healthy lifestyle management is becoming increasingly im-
portant in the Western world, as the incidence of obesity,
hypertension, and diabetes is taking on epidemic proportions
[1–3]. According to the World Health Organisation, 75 % of
cardiovascular diseases could be prevented by optimal life-
style management [4]. Indeed, the INTERHEART investiga-
tors have demonstrated that 90 % of (first) myocardial
infarctions (MIs) could be attributed to nine modifiable risks,
including hypertension, diabetes, and hypercholesterolaemia
[5]. Furthermore, smoking cessation, physical activity, mod-
erate alcohol consumption and combined dietary changes are
associated with mortality risk reductions of 20–45 % in pa-
tients with coronary artery disease (CAD) [6].
Several cardiac rehabilitation (CR) programs have been
developed since the 1980s for CAD patients, which offer a
variety of interventions that aim to stimulate an active and
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healthy lifestyle. In meta-analyses it has been demonstrated
that these programs effectively reduce the 1-year incidence
of total mortality, cardiovascular mortality and nonfatal MI
[7, 8]. However, these initial beneficial results were not
maintained during longer-term follow-up [9]. The lifestyle
changes adopted during the rehabilitation period were prob-
ably not incorporated into daily routine.
Throughout the past decades, patients who are referred
for CR constitute a heterogeneous and dynamically chang-
ing population. Nowadays, the majority of CR referrals
consist of patients who have survived an acute coronary
syndrome (ACS). Major changes have been implemented
in ACS treatment since the 1980s, which have highly
influenced mortality and morbidity. Currently, most ACS
patients undergo percutaneous coronary intervention (PCI)
in the acute phase, and receive antiplatelet therapy, lipid-
lowering therapy and other cardioprotective medication
during long-term follow-up. As a result, ACS patients
usually have preserved left ventricular function and, con-
sequently, a good survival [10, 11]. Also, the duration of
the hospital stay after ACS is considerably reduced;
the current average is approximately only 5 days [12].
Interestingly, CR programs have barely changed since the
1980s, and only few data are available on the optimal CR
format in ACS subjects [13–15].
The favourable developments in ACS treatment have,
however, an important downside: ACS patients have less
time for reflection on the event they experienced. The
contact time with healthcare professionals during the
acute phase is limited, whereas in this period patients
might be most open to accept (lifestyle) advice to avoid
future cardiac events. In order to adapt and maintain a
heart-healthy lifestyle, ACS patients therefore probably
need more guidance in the subacute phase than is cur-
rently offered in CR programs. Recently, some success-
ful maintenance programs have been presented [16–18]
However, these programs consist of high frequency con-
tacts during long-term follow-up, and may therefore not
be cost-effective. We postulated that CR programs
followed by relatively brief maintenance programs and
booster sessions, including behavioural techniques and
focusing on incorporating lifestyle changes into daily
life, can also improve long-term adherence to lifestyle
modifications [16, 19, 20]. These strategies might result
in improved (cardiac) mortality and morbidity in a cost-
effective fashion.
In the OPTImal CArdiac REhabilitation (OPTICARE)
trial we will assess the effects of two advanced and extended
CR programs that are designed to stimulate permanent
adaption of a heart-healthy lifestyle, compared with current
standard CR, in ACS patients. We will study the effects in
terms of cardiac risk profile, levels of daily physical activity,
quality of life and health care consumption.
Objectives
Primary objective
The primary objective of OPTICARE is to evaluate the
effectiveness of an extended CR program in patients
who have experienced an ACS. The program combines
physical activities, psychosocial counselling and person-
al coaching. Effectiveness will be expressed in terms of
levels of daily physical activity and (reduction in) esti-
mated cardiovascular risk, which will be measured by
the Systematic Coronary Risk Evaluation (SCORE)
function [21].
Secondary objectives
We have defined the following secondary objectives:
– To evaluate the effects of the extended CR programs on
physical fitness, body mass index (BMI), waist circum-
ference, health care consumption, quality of life, return
to work, occurrence of anxiety and depression, and
cardiovascular events;
– To evaluate which health benefits (cardiac risk profile,
physical fitness, quality of life, anxiety, depression,
participation, fatigue, health care consumption) are as-
sociated with improved levels of physical activity;
– To investigate whether extended CR is more cost-
effective than standard care.
Methods
The OPTICARE trial is a multicentre, open, multidisciplinary
randomised controlled trial with a 6-month follow-up. The
PRospective Open, Blinded Endpoint (PROBE) design will
be applied, and an independent Clinical Event Committee will
verify all cardiac events [22]. The protocol and procedures of
OPTICARE were approved by the Medical Ethics Committee
of Erasmus MC Rotterdam, the Netherlands.
Each patient will receive oral and written information
on the trial objectives, study design, and advantages and
disadvantages of study participation. A signed informed
consent form by the patient is a prerequisite for partici-
pation in the trial.
Patient selection
OPTICARE is designed for patients with a documented
ACS who are referred for CR . ACS is defined as persistent
(>20 min) chest pain suggestive of myocardial ischaemia,
which is unresponsive to nitroglycerin and which is accom-
panied by ST-T changes (electrocardiographic evidence)
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and/or cardiac troponin elevations (biochemical evidence),
regardless of in-hospital treatment. A total of 10 hospitals in
the broader region of Rotterdam—The Hague refer their
ACS patients to the local Capri Centre, which offers a
standard CR program that is consistent with the Dutch
guidelines [23, 24].
Allocated treatment
Eligible patients who consent to participate in the trial will
be randomly allocated to one of three treatment strategies
(Table 1), following inclusion and exclusion criteria as
mentioned in Table 2. Randomisation will be performed
by using sequentially numbered, opaque, sealed envelopes
with information on allocated treatment. The envelopes will
be prepared by an independent statistician, who uses a
random number generator to construct the treatment se-
quence. The allocation process will be monitored to pre-
serve randomness and concealment.
1) OPTICARE-Basic
Standard care (or: OPTICARE-Basic) consists of
standard CR according to the Dutch guidelines as is
currently offered to all patients referred to Capri
Cardiac Rehabilitation.
OPTICARE-Basic is a group exercise program of
1.5 h that is offered 2 times a week for 12 weeks under
the supervision of a physiotherapist. Participation in
multifactor lifestyle and cardiovascular risk factor group
education sessions is offered to all patients, and com-
prises: information on cardiovascular diseases risk fac-
tors, medical information, dietary advice, and advice on
coping with emotions. If indicated, there is an option to
participate in a smoking cessation program, nutritional
counselling sessions, stress management sessions or an
individually based psychological program.
At the start of the program, each patient will undergo
an intensive interview to determine his/her individual
program. Only the physical training program is strictly
obligatory; the counselling and group sessions will be
attended upon motivation of each patient.
2) OPTICARE-COACH
The 2nd strategy is based on the COACH study that
demonstrated favourable effects of personal coaching
[20]. In the OPTICARE-COACH arm of the trial, stan-
dard CR is extended with five telephone coaching ses-
sions with an interval of 5–6 weeks during the first
6 months after completion of standard CR. The
coaching sessions intend to keep the patient aware of
his or her cardiovascular risk factors, and on methods
learned to improve cardiovascular health. The personal
coaching is offered by specialised nurses, who are
trained to stimulate patients to pursue the target levels
for their particular coronary risk factors. This COACH-
based strategy consists of coaching the patient in a
process of continuous improvement in coronary risk
factors. Patients are stimulated to develop a personal
plan of action in which they measure their coronary risk
factors (e.g. at their general practitioner’s office), define
their targets, act upon, measure again, etc. Patients are
also persuaded to adopt and adhere to appropriate life-
style measures, including a healthy diet, persistent
smoking cessation, and daily physical activities at mod-
erate intensity.
3) OPTICARE-CAPRI
The 3rd strategy, OPTICARE-CAPRI, is another
extension of standard CR. Patients who are allocated
to this strategy have a commitment to participate in the
multifactorial lifestyle and cardiovascular risk factor
management group sessions (rather than participation
on a voluntary basis). Besides, during OPTICARE-
CAPRI CR patients will participate in three group
counselling sessions under the supervision of a physio-
therapist to promote an active lifestyle (aiming at regu-
lar exercise of moderate intensity for 30 min at least 5
times a week). The intrinsic motivation of the patient to
change behaviour will be encouraged by the motiva-
tional interviewing technique which has shown to be
effective in improving activity levels in daily life [25,
26]. To provide feedback on the patient’s home
activity, pedometers (Yamax Digiwalker SW-200)
will be provided [27]. Finally, at 4, 6 and 12 months
after the start of the program the patients will again
be required to participate in multifactor lifestyle and
cardiovascular risk factor group sessions of 2 h each
in which maintenance of healthy lifestyle behaviour
(including physical activity) is discussed to increase
long-term adherence. These group sessions are led
by physiotherapists, social workers, dietician, nurses
and physicians and are based on self-regulation. Finally,
in patients randomised to OPTICARE-CAPRI CR the
cholesterol and blood pressure levels will be monitored
and medication will be adjusted when needed. The target
level will be: LDL ≤1.8 mmol/l and systolic blood pres-
sure (SBP) <140 mmHg.
Data collection
Apart from the baseline clinical characteristics, the follow-
ing data will be collected by the OPTICARE team in all
patients at baseline (i.e. prior to CR), at the end of standard
CR, and at 1 year and 1.5 year after inclusion:
1) The 10-year CVD mortality risk according to the
SCORE risk chart, which is based on the following
factors: [16]
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– Age
– Sex
– Total cholesterol and HDL cholesterol measured in
blood samples after fasting for a minimum of 8 h
– Systolic blood pressure as measured by a trained
nurse
– Smoking status determined during an interview by
one of the social workers of the Capri cardiac
rehabilitation centre. The concentration of carbon
monoxide in breath will be measured using a breath
analyser (Smokerlyzer®).
2) The level of everyday physical activity:
The level of everyday physical activity is objectively
measured with a validated accelerometry-based activity
monitor (Actigraph GT3X, Fort Walton Beach,
Florida), for 7 consecutive days in the home situation.
The Actigraph is a small device worn on a belt around
the waist that measures and records movement,
movement intensity and duration. The Actigraph is
the most widely used (commercially available) ac-
celerometer and different studies report acceptable
to good validity [28].
3) A broad spectrum of characteristics and risk factors that
determine cardiovascular health
– Medication
– Blood glucose, blood lipids, and glomerular filtra-
tion rate. All blood samples are taken after a min-
imum of 8 h of fasting
– Body mass index (BMI) and waist circumference
– Physical fitness assessed by a 6-minute walk test
and a 5 times sit-to-stand test
– Working, marital, and educational status
– Information on return-to-work, quality of life, anx-
iety and depression, health care consumption, ill-
ness perception, medication adherence, perceived
physical activity, fatigue, self-efficacy, type D per-
sonality, social participation and movement fear.
We will use validated questionnaires to obtain these
data (Table 3).
Table 1 Treatment arms
OPTICARE-Basic Standard CR
OPTICARE-COACH Standard CR
5 Telephone calls after completion of standard CR for 6 months with an interval of 5 a 6 weeks
OPTICARE-CAPRI Standard CR with obligation to participate in the multifactorial lifestyle and
cardiovascular risk factor management group sessions
3 Counselling sessions during standard CR with an interval of 1 month to promote an active lifestyle
3 Multifactorial lifestyle and risk factor group sessions after completion of standard
CR (at 4/6/12 months post randomisation)
Titration of medication to LDL level<=1.8 mmol/l and SBP<=140 mmHg
Table 2 Inclusion and exclusion criteria
Inclusion criteria
Recent acute coronary syndrome
Age over 18 years
Proficient in the Dutch language
Providing written informed consent
Exclusion criteria
Heart failure and/or impaired left ventricular function
(left ventricular ejection fraction <40 %)
Angina NYHA Class II–IV
Psychological or cognitive impairments which may limit
cardiac rehabilitation
Congenital heart disease
Chronic obstructive pulmonary disease Gold classification ≥II
Diabetes with organ damage
Locomotive disorders that will preclude participation in an
exercise training program
Implantable cardio-defibrillator (ICD)
Renal failure needing follow-up by a nephrologist
Intermittent claudication impairing CR exercises
Table 3 Questionnaires
KVL H: Quality of Life Questionnaire [38]
HADS: Hospital Anxiety and Depression Scale [39]
IPQ: Illness Perception Questionnaire [40]
IPAQ: Self-perceived level of daily physical activity:
International Physical Activity Questionnaire [41]
FSS: Fatigue Severity Scale [42]
GSE: General Self-Efficacy [47]
DS14: Type-D personality [43]
USER P: User-Participation [44]
AVI scale: “Angst Voor Inspanning”(i.e. fear of movement:
self-designed questionnaire)
Smoking behaviour, self-designed questionnaire
EQ5D [45, 46]
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Study endpoints and sample size
The primary study endpoint is the SCORE Risk Score that is
measured 1.5 years post randomisation. The RESPONSE
trial [29] studied the effectiveness of a nurse-coordinated
outpatient risk management program in cardiac patients.
That strategy was associated with a 17 % reduction in
SCORE Risk Score as compared with standard care [21].
Based on these data, and taking into account the more
intensive interventions that we will perform, we expect in
both the OPTICARE-CAPRI and in the OPTICARE-
COACH arm at least a 20 % reduction in the SCORE
Risk Score at 1.5 years: from 5.40 to 4.32 points with
an estimated standard deviation (SD) of 4.5. With 274
patients in each treatment arm, the study has 80 %
power (beta-error=0.02) to detect this difference with
an alpha-error of 0.05 (2-sided test). We will enrol a
total 300 patients in each treatment arm, taking into
account a 10 % drop-out rate.
Secondary endpoints include all-cause mortality, cardio-
vascular mortality, non-fatal myocardial infarction, re-
hospitalisation for heart failure, re-hospitalisation for angi-
na, admission to the emergency room, non-fatal stroke, and
coronary intervention. All clinical endpoints will be moni-
tored and verified by an independent Clinical Event
Committee.
Cost effectiveness analysis
A cost-effectiveness analysis will be performed in accor-
dance with the current Dutch guidelines (Guidelines for
Pharmacoeconomic Evaluations) [30]. Costs will there-
fore be calculated from both the health care sector and
the societal perspective (where all costs are included in
the analysis regardless of who incurs them). Costs will
include direct medical costs, patient costs, and produc-
tivity losses. Unit prices for the most important cost
items will be determined using the micro-costing meth-
od, which is based on a detailed inventory and measure-
ment of all resources used. The primary health outcome
will be quality-adjusted life-years. Short-term costs and
effectiveness will be based on observed outcomes mea-
sured in this trial. Lifetime costs and health outcomes
will be calculated with a Markov model using data from
this trial in combination with literature data. Future costs
and life-years will be discounted at 4 % and 1.5 %
respectively. Extensive (probabilistic) sensitivity analyses
and value of information analysis will be performed.
Cost-effectiveness will be assessed by calculating the
incremental cost-effectiveness ratio, which is the differ-
ence between the mean costs of two treatment strategies
divided by the difference in their mean effects (e.g. life-
years) [31, 32].
Discussion
Over the past years it has been demonstrated that standard
CR reduces morbidity and mortality in patients with CAD
[7, 8, 14, 15]. An extended CR program consisting of
supervised 30 min aerobic exercise, comprehensive lifestyle
and risk factor counselling sessions may even further benefit
patients in the long term, as shown in the GOSPEL trial [16].
However, it should be realised that in this trial multiple (11
sessions in 3 years) and thus costly interventions were done. In
the COACH trial a limited number of telephone interventions
also had beneficial effects [20]. However, in that trial only
approximately half of the patients underwent CR and the
beneficial effect of the COACH intervention in the CR sub-
group is unknown. This is an important limitation of the
COACH trial since standard CR is recommended in the
Dutch guidelines [24]. In the OPTICARE study we will inves-
tigate in a separate study arm whether the COACH approach
still has beneficial effects in patients who suffered from anACS
and who subsequently underwent standard CR. In addition, the
effects of a more time-consuming OPTICARE arm, including a
limited number of extra sessions to promote a healthy lifestyle
with a focus on physical activity, will be studied.
Secondary prevention after an ACS has several compo-
nents. Preventive medication should be started and titrated
to optimal doses by the physician according to current
guidelines [11]. In addition, modifiable risk factors (diabe-
tes, hypertension, cholesterol, smoking, overweight, seden-
tary lifestyle) should be inventoried and appropriate action
should be taken in a combined effort of the patient and
physician. In most studies the pharmacological components
of the program showed benefits [11, 16, 20], but strategies
to promote smoking cessation and in particular physical
activity and weight loss are needed. Therefore, in this study,
we will focus on reaching long-term lifestyle changes, with
a special focus on increasing the level of physical activity.
Lifestyle inactivity is an important cardiovascular risk factor
and related to several cardiac risk factors such as lipid
profile, blood pressure and body composition [32]. Despite
the well-known beneficial effects of CR on physical fitness,
mortality and quality of life [31, 33], only little is known
about the effects of CR programs on the level of daily
physical activity after CR. In some studies positive effects
on daily physical activity after CR have been shown [9, 34],
but it has also been reported that physical activity tends to
decline 6 to 12 months after completion of standard CR [9,
35]. Furthermore, results from a study in patients with
chronic heart failure suggest that improved physical fitness
does not automatically result in a more active lifestyle [36].
The OPTICARE-CAPRI arm aims to incorporate daily
physical activity in one’s life and thus promotes long-term
adherence by maintenance programs and booster sessions at
4, 6 and 12 months post randomisation.
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In this era of financial constraints it is essential to not
only show beneficial effects of an intervention but also the
cost-effectiveness of the intervention. This may be particu-
larly true for comparing the less intensive COACH arm,
involving just some telephone contacts, with the more ex-
tensive CAPRI arm. Therefore, a full ex-post economic
evaluation of both extended CR programs and standard
CR will be performed [37].
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